- Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele2019 | Second Faculty of Medicine
- Response to elexacaftor/tezacaftor/ivacaftor in intestinal organoids derived from people with cystic fibrosis2022 | Second Faculty of Medicine
- Case report of two adults with F508del/3849+10 kb C > T genotype regaining exocrine pancreatic function following treatment with elexacaftor/tezacaftor/ivacaftorPublication without faculty affiliation
- Elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis ineligible for clinical trials: a 24-week observational study2023 | Second Faculty of Medicine
- Elexacaftor: next-generation modulator of the CFTR protein2021 | Second Faculty of Medicine
- CFTR protein modulators2019 | Second Faculty of Medicine
- Current possibilities of causal therapy of cystic fibrosis in childhood2021 | Faculty of Medicine in Pilsen
- Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells2021 | Second Faculty of Medicine